Archive for MHRA Updates
The Department of Health and Social Care has provided an update on the SSP for Fluoxetine 10mg tablets (SSP05)
Source: NHSBSA-SSP Update 10.08.2021 – The DHSC has provided an update on the Serious Shortage Protocols for Fluoxetine 10mg tablets (SSP05). This SSP has been varied – the revised end...
MHRA recalls contaminated Irbesartan- batches as precautionary measure
Patients should not stop any treatments without consulting their doctor or pharmacist Source: MHRA 9th August 2021 The MHRA today has issued a recall for 25 batches of Irbesartan-containing medicinal...
Field Safety Notices: 2 to 6 August 2021 List of field safety notices (FSNs) from medical device manufacturers from 2 to 6 August
Source: MHRA 9th August 2021 Overview If you receive a field safety notice (FSN) from a manufacturer you must always act on it. MHRA publishes the following for information only....
Class 2 Medicines Recall:Various Marketing Authorisation Holders and parallel distributor companies, Irbesartan-containing products, EL (21)A/19
Specific batches of products supplied by the Marketing Authorisation Holders and parallel distributor companies are being recalled due to presence of a mutagenic impurity. Source: MHRA 9th August 2021 Company...
Central Alert System- Tinzaparin Sodium Alert
Source: MHRA July 29, 2021 Unavailable From Mid October! MHRA has issued an alert via the Central Alert System for Tinzaparin sodium (10,000 IU/ml) 3,500 units in 0.35ml and 4,500...
Contractor Notice: SSP endorsement errors
Source: PSNC/ (NHSBSA) July 28, 2021 Following the announcement of the new Serious Shortage Protocols (SSP) endorsement which was introduced from 1 June 2021, PSNC has been working with NHS Business Services...
Medicine Supply Notification: Nexium® (esomeprazole) 10mg gastro-resistant granules sachets
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Nexium® (esomeprazole) 10mg gastro-resistant granules sachetsMSN/2021/038Tier 2 – medium impact Date of issue:...
Medicine Supply Notification: Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a medicine supply notification for Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solutionMSN/2021/036Tier 2 –...
Medicine Supply Notification: Catapres® (clonidine) 100microgram tablets
Source: PSNC/ (DHSC) July 21, 2021 Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Catapres® (clonidine) 100microgram tabletsMSN/2021/037 Tier 2 – medium impact Date of issue: 21/07/2021...
Class 4 Medicines Defect Information, Amoxicillin
Class 4 Medicines Defect Information, Amoxicillin 500 mg/ 5 ml Powder for oral suspension, (PL 25298/0248), EL (21)A/18 Click here for the source
National Patient Safety Alert -inappropriate anticoagulation of patients with a mechanical heart valve
A National Patient Safety Alert has been issued on the risk of inappropriate anticoagulation of patients with a mechanical heart valve. National Patient Safety Alert – Inappropriate anticoagulation of patients...
Class 4 Medicines Defect Information, Sevredol 10 mg and 20mg tablets
Class 4 Medicines Defect Information, Sevredol 10 mg and 20mg tablets, (PL 16950/0063, PL 16950/0064), EL (21)A/17 Napp Pharmaceuticals Limited have noticed and an error in the PIL of specific...
